UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000029613
Receipt number R000033828
Scientific Title Analysis of the expression of alpha-defensin in the joints of pyogenic arthritis
Date of disclosure of the study information 2017/12/01
Last modified on 2023/07/10 15:48:27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Analysis of the expression of alpha-defensin in the joints of pyogenic arthritis

Acronym

Analysis of the expression of alpha-defensin in the joints of pyogenic arthritis

Scientific Title

Analysis of the expression of alpha-defensin in the joints of pyogenic arthritis

Scientific Title:Acronym

Analysis of the expression of alpha-defensin in the joints of pyogenic arthritis

Region

Japan


Condition

Condition

Pyogenic arthritis

Classification by specialty

Orthopedics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study was to determine alpha defensin in infectious cases after prosthetic joint surgery and synovia derived from afflicted joints of purulent arthritis cases and clarify alpha defensin upregulation in synovial fluid of affected joints .

Basic objectives2

Others

Basic objectives -Others

Comparison with the results of laboratory data and bacterial examination

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Increase of alpha defensin in infected joints

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

80 years-old >

Gender

Male and Female

Key inclusion criteria

(1) Infection after artificial joint replacement surgery, cases of suppurative arthritis suspected
(2) Cases with local feeling of hotness, redness and swelling with physical findings
(3) Age: over 20 years old, under 80 years (at registration)

Key exclusion criteria

1) Patients wishing pregnant or pregnant
2) Persons who are participating in other clinical studies
3) In addition, patients who the doctor in charge judged as undesirable as subjects of this study

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Daisuke Chiba

Organization

Department of Orthopaedic Surgery, Graduate School of Medicine Tohoku University

Division name

Orthopaedic Surgery

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

0227177245

Email

d-chiba@med.tohoku.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Daisuke Chiba

Organization

Department of Orthopaedic Surgery, Graduate School of Medicine Tohoku University

Division name

Orthopaedic Surgery

Zip code


Address

1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi

TEL

812227177245

Homepage URL


Email

d-chiba@med.tohoku.ac.jp


Sponsor or person

Institute

Department of Orthopaedic Surgery, Graduate School of Medicine Tohoku University

Institute

Department

Personal name



Funding Source

Organization

Department of Orthopaedic Surgery, Graduate School of Medicine Tohoku University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 12 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2017 Year 10 Month 18 Day

Date of IRB

2017 Year 10 Month 18 Day

Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Analysis of the alpha defensin in the joints with infection


Management information

Registered date

2017 Year 10 Month 18 Day

Last modified on

2023 Year 07 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000033828


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name